Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

5% minoxidil works better for hair growth than 1% minoxidil.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Start low-dose minoxidil gradually, especially for women, to reduce side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Finasteride toxicity information is limited, poor quality, and biased.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Valproic acid increases hair count in men with hair loss.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.